Translational Development Acquisition Corp. (TDAC)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	190.50M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	19.05M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About TDAC

Translational Development Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. We intend to initially concentrate on target businesses making a positive contribution to human health in the healthcare or healthcare related industries. In particular, we will target North American or European companies in the life sciences and biotechnology sectors where our management has extensive investme...

• Industry: Shell Companies
• Sector: Financials
• Founded: 2022
• Country: United States
• Stock Exchange: NASDAQ
• Ticker Symbol: TDAC